Manufacture of pharmaceutical preparations
APPSENS AS
Revenue 2025
NOK 10.8m
Operating profit
NOK −10.4m
Equity
NOK 7.5m
Incorporated
2017
Employees
8
Share capital
NOK 128,000
Key figures · 2025
Current ratio
3.44
Equity ratio
49.4%
Key figures over time · 2025
| Key figures | 2025 | Trend |
|---|---|---|
| Lønnsomhet | ||
| Operating margin (%%) | -96.1% | |
| Net margin (%%) | -95.5% | |
| Return on assets (%%) | -68.4% | |
| Likviditet | ||
| Current ratio | 3.44 | |
| Working capital | 6.4m | |
| Soliditet | ||
| Equity ratio (%%) | 49.4% | |
| Debt-to-equity ratio | 1.03 | |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.